ODI Pharma AB (FRA:6OD) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6OD ODI Pharma AB FRA:6OD
47 GF Score
Price €0.17
GF Value €0.55
! 1 Warning Sign
View Full Analysis

What is ODI Pharma AB Net Loan?

Net Loan only applies to banks and insurance companies.

FRA:6OD
47GF Score
ODI Pharma AB FRA:6OD
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ODI Pharma AB (FRA:6OD) Overvalued in 2026?

Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued. The current stock price of €0.17 is trading 68.7% below its estimated GF Value™ of €0.55.

Key valuation signals for FRA:6OD:

  • Net Loan:
  • GF Value™: €0.55 vs. price of €0.17 (68.7% below fair value)
  • GF Score™: 47/100 with 1 warning sign

No single metric tells the full story. See the FRA:6OD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ODI Pharma AB Business Description

Other Exchanges ODI:Sweden
Address Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
47GF Score

Get the complete analysis for FRA:6OD

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.17
Price
€0.55
GF Value